About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.02% 0.000181846 95 K 95201
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.01% 0.000104896 11 K 10674
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.0% 2.9467E-05 10 K 9697
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.0% 4.37666E-05 17 K 17403
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.1 B 2.1424E+09 1,499 1499 0.01% 0.00011 244 K 243610
SBIO ALPS Medical Breakthroughs ETF 201.2 M 2.01211E+08 71 71 0.38% 0.0038 751 K 750739
VBK Vanguard Small-Cap Growth ETF 8.5 B 8.5E+09 622 622 0.01% 5E-05 440 K 439609
VHT Vanguard Health Care ETF 9.4 B 9.400001E+09 361 361 0.01% 5E-05 441 K 440625
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.03% 0.00026 73 K 73032
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,013 2013 0.01% 0.00013 215 K 215067
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.04% 0.0004 3.4 M 3385260
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 64 K 64174
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.01% 0.0001 5.2 M 5234540
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.02% 0.0002 2.1 M 2147910
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 94 K 94251
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.0% 3.64365E-05 59 K 58874
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 1,005 1005 0.0% 2.67137E-05 53 K 52931

Wait, Before You Leave...